---

Treatment management of congenital nasolacrimal duct atresia: A review article

---

Review Article

Author Details : Anurag Medatwal*, Puneet Singhvi, Ritu Medatwal, Manoj Garg

Volume : 9, Issue : 4, Year : 2023

Article Page : 485-488

https://doi.org/10.18231/j.ijceo.2023.093

Suggest article by email

Get Permission

---

Abstract

A atresia of nasolacrimal duct which is congenital in nature causing lacrimation and mucous secretion from the eyes. Nasolacrimal duct atresia is the most common disorder of newborns showing symptoms of this condition around 6 to 20 percent. Generally symptoms shows after birth within few weeks with excessive tears and discharge from eye which may be present in single or both eye. Both upper and lower eyelids redness may result due to irritation by tears and eye discharge. Due to this condition it presents like a chronic unilateral or bilateral conjunctivitis.Observation and conservative treatment is the best treatment in infants and nasolacrimal probing is the best treatment option for children above one year of age. But the timing for probing is still under debatable. Other surgical invasive methods like intubation of silicon tube, dilation by balloon catheter and (DCR) dacryocystorhinostomy. So aim of this review study is provide an update on congenital NLD Atresia treatment.
 

Keywords: Congenital nasolacrimal duct atresia, Lacrimal sac, Mucous secretion, Tears.

How to cite : Medatwal A, Singhvi P, Medatwal R, Garg M, Treatment management of congenital nasolacrimal duct atresia: A review article. Indian J Clin Exp Ophthalmol 2023;9(4):485-488

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.